Review
Genetics and hepatitis C: It’s good to be ‘CC’
Jose Mari Parungao, MD, Ibrahim A. Hanouneh, MD, Binu John, MD, Naim Alkhouri, MD and Nizar N. Zein, MD
Cleveland Clinic Journal of Medicine February 2015, 82 (2) 97-104; DOI: https://doi.org/10.3949/ccjm.82a.14004
Jose Mari Parungao
Department of Gastroenterology, Providence Hospital and Medical Centers, Southfield, MI
Ibrahim A. Hanouneh
Department of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland Clinic; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
Binu John
Department of Gastroenterol-ogy and Hepatology, Digestive Disease Institute, Cleveland Clinic; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
Naim Alkhouri
Department of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland Clinic
Nizar N. Zein
Department of Gastroenterol-ogy and Hepatology, Digestive Disease Institute, Cleveland Clinic; Associate Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH

ABSTRACT
The interleukin-28B (IL28B) gene contains a single-nucleotide polymorphism at location rs12979860 that affects both the natural history of hepatitis C virus infection and the patient’s response to treatment, particularly interferon-based regimens with or without protease inhibitors.
- Copyright © 2015 The Cleveland Clinic Foundation. All Rights Reserved.
In this issue
Cleveland Clinic Journal of Medicine
Vol. 82, Issue 2
1 Feb 2015
Genetics and hepatitis C: It’s good to be ‘CC’
Jose Mari Parungao, Ibrahim A. Hanouneh, Binu John, Naim Alkhouri, Nizar N. Zein
Cleveland Clinic Journal of Medicine Feb 2015, 82 (2) 97-104; DOI: 10.3949/ccjm.82a.14004
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.